The combined CD38/CD49d phenotype was the strongest FC-based predictor of overall survival and the treatment-free survival in large cohorts of patients with CLL [50,51], supporting the previous suggestion of the scoring system based on the expression of several cell-surface antigens for correct risk stratification in CLL [52]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.